Company Encyclopedia
View More
name
HAIER BIOMEDICAL
688139.SH
Qingdao Haier Biomedical Co.,Ltd engages in the research and development, manufacture, marketing, and sale of low temperature storage equipment for biomedical samples in China and internationally. The company offers ULT freezers, pharmacy refrigerators, freezers, automatic storage solutions, cryogenics, active temperature controlled RKN containers, transport coolers, and RTMD products; and CO2 incubation, standard incubators, biological safety cabinets, clean benches and laminar, and sterilization products. It also provides floor standing, benchtop refrigerated, and benchtop centrifuges; intelligent pharmacy automation and RFID pharmacy products; blood bank refrigerators, blood component management products, blood plasma freezers, and transport coolers; and vaccine storage, cold/freezer room, medical waste disposal equipment, and other products. In addition, the company offers freezer and controlled rate freezers; UV visible spectrophotometer and total organic carbon analyzer products; and consumables.
890.25 B
688139.SHMarket value -Rank by Market Cap -/-

Financial Score

08/12/2025 Update
C
Health Care EquipmentIndustry
Industry Ranking35/63
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE5.93%C
    • Profit Margin11.31%B
    • Gross Margin47.46%B
  • Growth ScoreC
    • Revenue YoY1.18%C
    • Net Profit YoY-28.53%D
    • Total Assets YoY0.16%C
    • Net Assets YoY0.97%C
  • Cash ScoreC
    • Cash Flow Margin884.39%B
    • OCF YoY1.18%C
  • Operating ScoreC
    • Turnover0.4C
  • Debt ScoreA
    • Gearing Ratio18.85%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Haier Biomedical: Cumulatively repurchased shares worth 84.1156 million yuan for employee incentives

    HAIER BIOMEDICAL announced that the company will repurchase shares through a centralized bidding trading method on January 13, 2025, with a repurchase fund of 100 million to 200 million yuan, for the employee stock ownership plan or equity incentive, with a deadline until January 13, 2026. As of October 31, 2025, a total of 2.5903 million shares have been repurchased, accounting for 0.8147% of the total share capital, with a repurchase amount of 84.1156 million yuan and a repurchase price of 29.86 to 34.69 yuan per share

    Zhitong·
    SH
    688139
    +1.46%
    Zhitong·
    SH
    688139
    +1.46%

    Haier Biomedical: Jiu Shi You Xuan No. 1 Private Securities Investment Fund has become a shareholder with over 5% stake in the company

    HAIER BIOMEDICAL announced that JiuShi YouXuan No. 1 Private Securities Investment Fund has increased its holdings in the company by a total of 15,897,909 shares through centralized bidding and block trading in the secondary market, accounting for 5.00% of the company's total share capital. The funds for this increase in holdings come from its own funds. After this change in equity, JiuShi YouXuan No. 1 has become a shareholder holding more than 5% of the company

    Zhitong·
    SH
    688139
    +1.46%
    Zhitong·
    SH
    688139
    +1.46%

    HAIER BIOMEDICAL: Net profit in the first half of 2025 decreased by 39.09% year-on-year

    HAIER BIOMEDICAL announced that in the first half of 2025, operating revenue was 1.196 billion yuan, a year-on-year decrease of 2.27%. The net profit attributable to shareholders of the listed company was 143 million yuan, a year-on-year decrease of 39.09%. The basic earnings per share were 0.45 yuan/share, a year-on-year decrease of 39.19%

    Zhitong·
    SH
    688139
    +1.46%
    Zhitong·
    SH
    688139
    +1.46%

    HAIER BIOMEDICAL: Net profit of 110 million yuan in the first quarter of 2025, a year-on-year decrease of 19.88%

    HAIER BIOMEDICAL announced that its operating revenue in the first quarter of 2025 was 689 million yuan, a year-on-year increase of 0.30%. The net profit was 110 million yuan, a year-on-year decrease of 19.88%

    Zhitong·
    SH
    688139
    +1.46%
    Zhitong·
    SH
    688139
    +1.46%

    Haier Biomedical: Haichuangzhi has cumulatively increased its holdings in the company by 5.7293 million shares

    HAIER BIOMEDICAL announced that Haichuangzhi increased its holdings by 5.7293 million shares on April 10, 2025, accounting for 1.8% of the total share capital, with an increase amount of 181.8369 million yuan (excluding transaction fees). The increase plan has been completed

    Zhitong·
    SH
    688139
    +1.46%
    Zhitong·
    SH
    688139
    +1.46%
    © 2025 Longbridge｜Disclaimer